✦ LIBER ✦

94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer

✍ Scribed by H.T. Greinix; W. Linkeach; M. Seifert; E. Kubista; K. Czerwendka; S.A. Brugger; F. Keil; P. Sevelda; M. Kurz; P. Kaths; A.K.H. Vienne

Book ID: 116168369
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 180 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)84848-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Dose Chemotherapy and Stem Cell Sup

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer

✍ Renee M. Gerrero, Steven Stein, Dr Edward A. Stadtmauer 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 158 KB

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy

✍ Giralt, S A; Gajewski, J L; Donato, M L; Cristofanilli, M; Ueno, N T; Konoplev, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Radiotherapy after high-dose chemotherap

Radiotherapy after high-dose chemotherapy and peripheral blood stem cell support in high-risk breast cancer

✍ Ulrike Hoeller; Juergen Heide; Nicolaus Kroeger; William Krueger; Fritz Jaenicke 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen

Adjuvant High-Dose Chemotherapy with Aut

Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

✍ Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 467 KB

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views